Antal Martinecz, PhD, is Associate Director of Pharmacometrics at Certara Japan, with drug development experience across Japan, Europe, and North America. He specializes in model-informed drug development, with expertise in population PK and PD across diverse therapeutic areas, including pediatrics, rare diseases, metabolic disorders, and immunology. Prior to joining Certara, he focused on population PK and PD as well as translational modeling in respiratory and bacterial infectious diseases.